award

Phase 2 Study of Vascular-Targeted Prodrug (G-202) for the Treatment of Recurrent Glioblastoma

  • Award Number: R01FD005077

  • ORGANIZATION: FOOD AND DRUG ADMINISTRATION

  • OPDIV: FDA

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)